Volume Kinetics of Fluid Resuscitation in Early Sepsis
Key facts
- Who runs it
- Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
- Where
- Romania2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 13 people enrolled
- Started
- 19 Jun 2024
- Ended
- 1 Oct 2026
- Type of study
- Observational
- Treatments tested
- Ringer's Lactate
- Record updated
- 20 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- A diagnosis of sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation:
- hypotension requiring norepinephrine to maintain a mean arterial blood pressure (MAP) either predefined by the clinician or at 65 mm Hg or higher and/or
- a serum lactate level >2 mmol/L (18mg/dL) and/or
- acute oliguria defined as urine output <0.5mL/kg/hr and/or
- mottled skin and/or
- capillary refill time > 3 seconds
Who cannot take part
- Administration of at least 1 L of IV fluid in the last 6 hours prior to screening. All crystalloids, colloids and blood products that the patient has received are counted
- Concurrent haemorrhagic or obstructive shock
- Competing causes of lactic acidosis including: seizures within 3 hours of enrollment, use of linezolid or metformin or anti-retrovirals at the time of enrollment, carbon monoxide or cyanide poisoning, highly suspected or known ischemic bowel, and known mitochondrial disorders
- End-stage renal disease that requires chronic dialysis
- Increased risk of fluid intolerance:; Echocardiographic evidence of moderate or severe left ventricular systolic dysfunction; Echocardiographic evidence of moderate or severe right ventricular systolic dysfunction; Hypoxemia index < 200 mmHg or sonographic evidence of bilateral B or C profile; Abdominal compartment syndrome
- Post-cardiac arrest
- Known pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.
The group in the trial
- Ringer's Lactate
Adult patients admitted in the intensive care unit (ICU) with sepsis, as defined by the Sepsis-3 criteria and exhibiting sepsis-induced hypoperfusion prior to the administration of adequate volume resuscitation (i.e., 30 ml/kg crystalloid).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Volume Kinetics of Fluid Resuscitation With 30 ml/kg Ringer Lactate in Early Sepsis
- Record updated
- 20 October 2026